DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148 | +13.8% | 10,000 | -0.2% | 0.01% | +16.7% |
| Q2 2023 | $130 | +32.7% | 10,025 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $98 | -8.4% | 10,025 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $107 | -99.9% | 10,025 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $105,000 | -46.2% | 10,025 | -35.4% | 0.01% | -40.0% |
| Q2 2022 | $195,000 | +16.1% | 15,525 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $168,000 | -22.9% | 15,525 | +0.2% | 0.01% | -20.0% |
| Q4 2021 | $218,000 | -9.2% | 15,500 | +24.0% | 0.01% | -9.1% |
| Q3 2021 | $240,000 | +95.1% | 12,500 | 0.0% | 0.01% | +120.0% |
| Q2 2021 | $123,000 | +48.2% | 12,500 | -13.8% | 0.01% | +25.0% |
| Q4 2019 | $83,000 | +59.6% | 14,500 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $52,000 | – | 14,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |